Trials / Unknown
UnknownNCT04510870
Iron Deficiency as an Ignored Cause of Infertility
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Dextra Fertility Clinic · Academic / Other
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
Iron deficiency may play a critical role in human infertility, oocyte quality and may even play a role in endometrial receptivity. By correcting iron deficiency, low ferritin values, in infertile women with intravenous iron supplementation, embryo quality and pregnancy rates may improve. The main objective is to evaluate the effect of intravenous iron supplementation on embryo quality (number of good quality blastocysts). Randomized, double blind, parallel group, cross-over study of ferric carboxymaltose compared to placebo (NaCl infusion).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferric Carboxymaltose Injection | Infusion prior the start of IVF/ICSI cycle. Dosing according to the summary of product characteristics (SmPC) chart. Placebo infusion before frozen embryo transfer if needed. |
| DRUG | NaCl infusion | Placebo infusion prior the start of IVF/ICSI cycle. Ferric Carboxymaltose infusion before frozen embryo transfer if needed. Dosing according to the summary of product characteristics (SmPC) chart. |
Timeline
- Start date
- 2020-08-17
- Primary completion
- 2021-12-31
- Completion
- 2022-02-28
- First posted
- 2020-08-12
- Last updated
- 2020-08-12
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT04510870. Inclusion in this directory is not an endorsement.